GSK, Pfizer, Others Targeted In DNA Patent Suit
Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Pfizer Inc. and others were hit with a suit in Colorado on Wednesday alleging they infringe a patent for technology using DNA in genetic analysis....To view the full article, register now.
Already a subscriber? Click here to view full article